The findings from several new studies have added fuel to the debate surrounding the use of dual therapy, or a 1-week, low-dose regimen comprising omeprazole in combination with 2 antibacterial agents, for the eradication ofHelicobacter pyloriinfection. On another note, a study in patients with nonulcer dyspepsia has demonstrated that eradicatingH. pyloriinfection does not improve the severity of symptoms.Inpharma® brings you a taste of the issues surroundingH. pyloriinfection that were a major focus of discussion at Digestive Disease Week [San Diego, US; May 1995].